wellbutrin xl

Generic: bupropion hydrochloride

Labeler: bausch health us llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name wellbutrin xl
Generic Name bupropion hydrochloride
Labeler bausch health us llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Bausch Health US LLC

Identifiers & Regulatory

Product NDC 0187-0730
Product ID 0187-0730_22308f71-fc56-430d-b559-bed47e17a46c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021515
Listing Expiration 2027-12-31
Marketing Start 2003-08-29

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01870730
Hyphenated Format 0187-0730

Supplemental Identifiers

RxCUI
993541 993545 993557 993564
UPC
0301870730302 0301870731309
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name wellbutrin xl (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number NDA021515 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)
source: ndc

Packages (3)

0187-0730-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07) 0187-0730-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30) 0187-0730-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

WELLBUTRIN XL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "22308f71-fc56-430d-b559-bed47e17a46c", "openfda": {"upc": ["0301870730302", "0301870731309"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993545", "993557", "993564"], "spl_set_id": ["a435da9d-f6e8-4ddc-897d-8cd2bf777b21"], "manufacturer_name": ["Bausch Health US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)", "package_ndc": "0187-0730-07", "marketing_start_date": "20030829"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)", "package_ndc": "0187-0730-30", "marketing_start_date": "20030829"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)", "package_ndc": "0187-0730-90", "marketing_start_date": "20030829"}], "brand_name": "WELLBUTRIN XL", "product_id": "0187-0730_22308f71-fc56-430d-b559-bed47e17a46c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0187-0730", "generic_name": "bupropion hydrochloride", "labeler_name": "Bausch Health US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "WELLBUTRIN", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "NDA021515", "marketing_category": "NDA", "marketing_start_date": "20030829", "listing_expiration_date": "20271231"}